200 related articles for article (PubMed ID: 20068136)
1. The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats.
Sato N; Kaneko M; Tamura M; Kurumatani H
Diabetes; 2010 Apr; 59(4):1092-100. PubMed ID: 20068136
[TBL] [Abstract][Full Text] [Related]
2. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
3. Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice.
Inoue E; Ichiki T; Takeda K; Matsuura H; Hashimoto T; Ikeda J; Kamiharaguchi A; Sunagawa K
J Endocrinol; 2012 Jun; 213(3):285-91. PubMed ID: 22460613
[TBL] [Abstract][Full Text] [Related]
4. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
[TBL] [Abstract][Full Text] [Related]
5. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
[TBL] [Abstract][Full Text] [Related]
6. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
7. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats.
Justo ML; Rodriguez-Rodriguez R; Claro CM; Alvarez de Sotomayor M; Parrado J; Herrera MD
Eur J Nutr; 2013 Mar; 52(2):789-97. PubMed ID: 22661284
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of diabetic nephropathy in OLETF rats by prostaglandin I(2) analog, beraprost sodium.
Watanabe M; Nakashima H; Mochizuki S; Abe Y; Ishimura A; Ito K; Fukushima T; Miyake K; Ogahara S; Saito T
Am J Nephrol; 2009; 30(1):1-11. PubMed ID: 19158439
[TBL] [Abstract][Full Text] [Related]
10. Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.
Oakes ND; Thalén P; Hultstrand T; Jacinto S; Camejo G; Wallin B; Ljung B
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R938-46. PubMed ID: 16183630
[TBL] [Abstract][Full Text] [Related]
11. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats.
Aldini G; Orioli M; Rossoni G; Savi F; Braidotti P; Vistoli G; Yeum KJ; Negrisoli G; Carini M
J Cell Mol Med; 2011 Jun; 15(6):1339-54. PubMed ID: 20518851
[TBL] [Abstract][Full Text] [Related]
12. Effects of beraprost sodium, a prostacyclin analogue, on tail flick response in two models of diabetic-neuropathy in rats and its mechanism.
Ueno Y; Koike H; Annoh S; Nishio S
Life Sci; 1996; 59(9):PL105-10. PubMed ID: 8761032
[TBL] [Abstract][Full Text] [Related]
13. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
14. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Park SH; Farooq MA; Gaertner S; Bruckert C; Qureshi AW; Lee HH; Benrahla D; Pollet B; Stephan D; Ohlmann P; Lessinger JM; Mayoux E; Auger C; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2020 Feb; 19(1):19. PubMed ID: 32070346
[TBL] [Abstract][Full Text] [Related]
17. Effects of salt rich diet in the obese Zucker rats: studies on renal function during isotonic volume expansion.
Pamidimukkala J; Jandhyala BS
Clin Exp Hypertens; 2004 Jan; 26(1):55-67. PubMed ID: 15000297
[TBL] [Abstract][Full Text] [Related]
18. Effects of fructose feeding on lipid parameters in obese and lean, diabetic and nondiabetic Zucker rats.
Koh ET; Mueller J; Osilesi O; Knehans A; Reiser S
J Nutr; 1985 Oct; 115(10):1274-84. PubMed ID: 3900313
[TBL] [Abstract][Full Text] [Related]
19. Use of glycated hemoglobin to assess Glycemic control in Wistar diabetic fatty rats and Zucker fatty rats.
Albright AL; Johnson PR; Greene S; Stern JS
Obes Res; 1994 Nov; 2(6):535-9. PubMed ID: 16358402
[TBL] [Abstract][Full Text] [Related]
20. Consumption of a high β-glucan barley flour improves glucose control and fatty liver and increases muscle acylcarnitines in the Zucker diabetic fatty rat.
Brockman DA; Chen X; Gallaher DD
Eur J Nutr; 2013 Oct; 52(7):1743-53. PubMed ID: 23229409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
